2008
DOI: 10.1088/0031-9155/53/5/016
|View full text |Cite
|
Sign up to set email alerts
|

A potential method forin vivorange verification in proton therapy treatment

Abstract: Proton therapy potentially offers excellent dose conformality and reduction in integral dose. The superior dose distribution is, however, much more sensitive to the radiological depth along the beam path than for photon fields. Variations in this depth due to inaccurate planning calculation, setup uncertainty, respiration-induced organ motion, etc, could result in either an 'undershooting', missing the distal portion of the target volume entirely, or an 'overshooting', delivering the full prescription dose to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
85
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 62 publications
(87 citation statements)
references
References 18 publications
2
85
0
Order By: Relevance
“…This simplified approach may be less accurate for WET computation, but has the advantage that the PDRs can be computed quickly. Regardless of the approach, techniques to experimentally validate calculated WET values include proton radiography, (12) proton range probe, (27) or an in vivo dosimetry method (28) …”
Section: Discussionmentioning
confidence: 99%
“…This simplified approach may be less accurate for WET computation, but has the advantage that the PDRs can be computed quickly. Regardless of the approach, techniques to experimentally validate calculated WET values include proton radiography, (12) proton range probe, (27) or an in vivo dosimetry method (28) …”
Section: Discussionmentioning
confidence: 99%
“…By comparing the WEPL from the actual treatment session to the WEPL from the first day of treatment one can verify if the total cumulated WEPL changes during the course of the treatment have become unacceptable for continuing use of the same treatment plan. The effectiveness of this approach should be first validated against an independent technique for range verification such as prompt gamma camera measurement, 19 , 20 the PET method, (7 – 9) proton radiography, (10) or the in vivo time resolved dose rate method 11 , 12 , 13 , 14 , 15 …”
Section: Discussionmentioning
confidence: 99%
“…It is obvious that using CBCT for detecting any relative changes in patient WEPL along the treatment beam path does not enable direct verification of the proton beam range; however, it can be used to indirectly derive the beam range correction for this particular treatment session. That is because one can quantify the needed range correction by relating the measured relative changes in the WEPL computed using CBCT data to the already base‐lined WEPL from previous treatment sessions where the beam range was actually verified by the PET method 7 , 9 or other in vivo range verification techniques like time resolved dosimetry 12 , 13 , 14 , 15 …”
Section: Introductionmentioning
confidence: 99%
“…Therefore, Melancon et al 6 proposed a liquid scintillation detector to be inserted into the rectum, combined with a wedge compensator to measure the range before treatment. Lu 7 proposed to use a time-dependent dose consistent with a passively scattered beam. These devices are under development and may be suited for body sites where a detector can be inserted; such a device would not be feasible for lung or abdominal tumors.…”
Section: Introductionmentioning
confidence: 99%